| Source: |
| Type: |
| miR-195 is commonly downregulated and acts as a tumour suppressor. Reduced miR-195 can release inhibition of cell-cycle, survival, angiogenesis, EMT, and drug-resistance genes.
MicroRNA-195 (miR-195; commonly miR-195-5p) is a small non-coding RNA belonging to the miR-15/16/195/424/497 family. It regulates gene expression by binding target messenger RNAs and promoting transcript degradation or translational repression. In many cancers, miR-195 ↓ is the more commonly reported pattern, and miR-195 generally functions as a tumour-suppressive microRNA. Restoration or miR-195 ↑ can inhibit cell-cycle progression, proliferation, migration, invasion, angiogenesis, epithelial-mesenchymal transition, and treatment resistance while promoting apoptosis in susceptible cancer models. Reported targets include CCND1, CCNE1, CDK4, CDK6, E2F3, BCL2, BCL2L2, BIRC5, VEGF, and FGF2/bFGF. Cancer review; Recent clinical review. |
| 6985- | Form, | Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1554 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid